id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1997-N-0041-0004,FDA,FDA-1997-N-0041,"Guidance for Industry on Levothyroxine Sodium Products-Enforcement of August 14, 2001, Compliance Date and Submission of New Applications; Availability",Notice,NAD-Notice of Availability of Data,2001-07-18T04:00:00Z,2001,7,,,2009-01-24T19:59:15Z,,0,0,09000064805cfc48